FDA
approval
· 2013-01-25
FDA Approved: ALOGLIPTIN — Original Application (Padagis Israel Pharmaceuticals Ltd)
Summary
The FDA approves the original application for alogliptin for adults with type 2 diabetes mellitus to improve glycemic control.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ALOGLIPTIN (ALOGLIPTIN)